Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease
NCT ID: NCT02670993
Last Updated: 2016-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2016-01-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nonverbal Communication in Aged People
NCT04146688
Non-pharmacological Care of Alzheimer's Disease: Benefice of Musical Interventions
NCT02833870
Effect of Music Therapy on Anxiety of Caregivers of Alzheimer's Disease Patients
NCT05317910
Music Therapy in Alzheimer's Disease
NCT02020356
Lexical Priming by Music in Alzheimer's Disease and Healthy Aging
NCT03342326
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary outcome is to evaluate the singing support on physical pain, by comparison with a control activity : "painting session".
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group : Singing sessions.
Patients will participate to singing working sessions. They will continue to take their usual treatments during the study period.
Singing sessions.
Patients will be in singing work groups, and will participate to these sessions during 12 weeks, with one session per week of 2 hours.
Control group : Painting sessions.
Patients will continue to participate to painting work sessions, and to take their usual treatments during the study.
Painting sessions.
Patients will be in painting groups, they will participate to this work session during 12 weeks, with one session of 2 hours per week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Painting sessions.
Patients will be in painting groups, they will participate to this work session during 12 weeks, with one session of 2 hours per week.
Singing sessions.
Patients will be in singing work groups, and will participate to these sessions during 12 weeks, with one session per week of 2 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Delay of at least one month between the diagnosis and the early work sessions
* If use of psychotropic drugs, they must be stabilized for 3 month
* If analgesics consumption level 2 or 3 they must be stabilized for 1 month
* With a score greater than or equal to 22 on the simplified visual scale (EVS) pain.
* Visual capabilities , auditory and oral or written expression in French language sufficient for conducting clinical and neuropsychological evaluations;
* MMSE \> 20
* Patient affiliated or entitled to a social security scheme
Exclusion Criteria
* Patients with severe disease, progressive or unstable nature which may interfere with the evaluation variables
* Patient with blindness or deafness could compromise its assessment
* Patient under guardianship
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ROUCH Isabelle, MD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices civils de Lyon
Lyon, , France
Chu Saint Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A01404-45
Identifier Type: OTHER
Identifier Source: secondary_id
1508071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.